🇺🇸 GroupB:Liposomal bupivacaine and bupivacaine hydrochloride; in United States

GroupB:Liposomal bupivacaine and bupivacaine hydrochloride; (GroupB:Liposomal bupivacaine and bupivacaine hydrochloride;) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

GroupB:Liposomal bupivacaine and bupivacaine hydrochloride; in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is GroupB:Liposomal bupivacaine and bupivacaine hydrochloride; approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for GroupB:Liposomal bupivacaine and bupivacaine hydrochloride; in United States?

Yongtao Sun is the originator. The local marketing authorisation holder may differ — check the official source linked above.